Bulletin
Investor Alert

Edwards Lifesciences Corp.

NYS: EW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 22, 2021, 7:53 p.m.

EW
/zigman2/quotes/205745196/composite

$

85.50

Change

-0.02 -0.02%

Volume

Volume 65,003

Quotes are delayed by 20 min

/zigman2/quotes/205745196/composite

Today's close

$ 87.23

$ 85.52

Change

-1.71 -1.96%

Day low

Day high

$85.21

$87.38

Open

52 week low

52 week high

$51.51

$92.08

Open

Company Description

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes tech...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Valuation

P/E Current

53.04

P/E Ratio (with extraordinary items)

69.31

P/E Ratio (without extraordinary items)

47.29

Price to Sales Ratio

11.39

Price to Book Ratio

11.76

Price to Cash Flow Ratio

41.97

Enterprise Value to EBITDA

37.01

Enterprise Value to Sales

11.19

Total Debt to Enterprise Value

0.01

Efficiency

Revenue/Employee

312,806.00

Income Per Employee

75,317.00

Receivables Turnover

7.65

Total Asset Turnover

0.74

Liquidity

Current Ratio

3.31

Quick Ratio

2.60

Cash Ratio

1.68

Profitability

Gross Margin

73.43

Operating Margin

27.55

Pretax Margin

26.83

Net Margin

24.08

Return on Assets

17.73

Return on Equity

28.73

Return on Total Capital

27.98

Return on Invested Capital

24.53

Capital Structure

Total Debt to Total Equity

16.36

Total Debt to Total Capital

14.06

Total Debt to Total Assets

10.46

Long-Term Debt to Equity

15.75

Long-Term Debt to Total Capital

13.53

Officers and Executives

Name Age Officer Since Title
Mr. Michael A. Mussallem 66 2000 Chairman & Chief Executive Officer
Mr. Scott B. Ullem 52 2014 Chief Financial Officer & Vice President
Dr. John P. McGrath 59 2006 Vice President-Quality, Regulatory & Clinical
Dr. Todd J. Brinton - 2019 Chief Scientific Officer & VP-Advanced Technology
Mr. Jean-Luc Lemercier - 2017 Corporate Vice President

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/15/2021 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
01/15/2021 Michael A. Mussallem
Chairman & CEO; Director
98,550   Derivative/Non-derivative trans. at $13.98 per share. 1,377,729
01/15/2021 Huimin Wang
CVP, Japan & Intercontinental
11,649   Derivative/Non-derivative trans. at $13.98 per share. 162,853
01/15/2021 Catherine M. Szyman
CVP, Critical Care
3,389   Derivative/Non-derivative trans. at $22.29 per share. 75,540
01/15/2021 Michael A. Mussallem
Chairman & CEO; Director
63,242   Disposition at $87.46 per share. 5,531,145
01/15/2021 Michael A. Mussallem
Chairman & CEO; Director
5,308   Disposition at $87.93 per share. 466,732
01/15/2021 Huimin Wang
CVP, Japan & Intercontinental
11,730   Disposition at $87.27 per share. 1,023,677
01/15/2021 Catherine M. Szyman
CVP, Critical Care
3,389   Disposition at $87.27 per share. 295,758
01/15/2021 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
01/08/2021 Donald E. Bobo
CVP,Strategy/Corp Development
8,400   Disposition at $90.22 per share. 757,848
01/08/2021 Donald E. Bobo
CVP,Strategy/Corp Development
4,677   Disposition at $90.85 per share. 424,905
01/08/2021 Donald E. Bobo
CVP,Strategy/Corp Development
13,077   Derivative/Non-derivative trans. at $13.98 per share. 182,816
01/04/2021 Jean-Luc Lemercier
CVP, EMEA, Canada, Latin Amer
20,523   Disposition at $91.24 per share. 1,872,518
01/04/2021 Jean-Luc Lemercier
CVP, EMEA, Canada, Latin Amer
7,503   Derivative/Non-derivative trans. at $11.35 per share. 85,159
01/04/2021 Jean-Luc Lemercier
CVP, EMEA, Canada, Latin Amer
13,020   Derivative/Non-derivative trans. at $13.98 per share. 182,019
12/15/2020 Larry L. Wood
CVP, TAVR
9,922   Disposition at $84.16 per share. 835,035
12/15/2020 Larry L. Wood
CVP, TAVR
800   Disposition at $84.83 per share. 67,864
12/15/2020 Larry L. Wood
CVP, TAVR
10,722   Derivative/Non-derivative trans. at $21.76 per share. 233,310
12/14/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
12/14/2020 Michael A. Mussallem
Chairman & CEO; Director
34,389   Disposition at $84.05 per share. 2,890,395
12/14/2020 Michael A. Mussallem
Chairman & CEO; Director
33,961   Disposition at $84.92 per share. 2,883,968
12/14/2020 Michael A. Mussallem
Chairman & CEO; Director
200   Disposition at $85.69 per share. 17,138
12/14/2020 Huimin Wang
CVP, Japan & Intercontinental
11,396   Disposition at $84.52 per share. 963,189
12/14/2020 Huimin Wang
CVP, Japan & Intercontinental
253   Disposition at $85.15 per share. 21,542
12/14/2020 Huimin Wang
CVP, Japan & Intercontinental
84   Disposition at $84.53 per share. 7,100
12/14/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
12/14/2020 Michael A. Mussallem
Chairman & CEO; Director
98,550   Derivative/Non-derivative trans. at $13.98 per share. 1,377,729
12/14/2020 Huimin Wang
CVP, Japan & Intercontinental
11,649   Derivative/Non-derivative trans. at $13.98 per share. 162,853
12/11/2020 Donald E. Bobo
CVP,Strategy/Corp Development
12,774   Disposition at $84.63 per share. 1,081,063
12/11/2020 Donald E. Bobo
CVP,Strategy/Corp Development
300   Disposition at $85.59 per share. 25,677
12/11/2020 Donald E. Bobo
CVP,Strategy/Corp Development
13,074   Derivative/Non-derivative trans. at $13.98 per share. 182,774
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
98,550   Derivative/Non-derivative trans. at $13.98 per share. 1,377,729
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
35,205   Disposition at $85.19 per share. 2,999,113
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
30,345   Disposition at $84.82 per share. 2,573,862
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
2,400   Disposition at $86.51 per share. 207,624
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
600   Disposition at $87.37 per share. 52,422
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
11/16/2020 Steven R. Loranger
Director
19,797   Derivative/Non-derivative trans. at $35.2 per share. 696,854
11/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
12,213   Disposition at $80.52 per share. 983,390
11/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
861   Disposition at $81.09 per share. 69,818
11/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
13,074   Derivative/Non-derivative trans. at $13.98 per share. 182,774
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
8,290   Disposition at $81.01 per share. 671,572
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
3,359   Disposition at $81.76 per share. 274,631
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
81   Disposition at $81.76 per share. 6,622
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
11,649   Derivative/Non-derivative trans. at $13.98 per share. 162,853
/news/latest/company/us/ew

MarketWatch News on EW

  1. Edwards Lifesciences Corp. stock falls Friday, underperforms market

    6:09 p.m. Dec. 11, 2020

    - MarketWatch Automation

  2. Edwards Lifesciences stock price target raised to $100 vs. $95 at Stifel

    7:44 a.m. Dec. 11, 2020

    - Ciara Linnane

  3. Edwards Lifesciences Corp. stock price target raised to $96 vs. $90 at Raymond James

    7:23 a.m. Dec. 11, 2020

    - Ciara Linnane

  4. Edwards Lifesciences Corp. stock falls Tuesday, underperforms market

    6:09 p.m. Dec. 8, 2020

    - MarketWatch Automation

  5. Edwards Lifesciences Corp. stock outperforms market on strong trading day

    6:10 p.m. Dec. 4, 2020

    - MarketWatch Automation

  6. Edwards Lifesciences Corp. stock falls Thursday, underperforms market

    6:10 p.m. Dec. 3, 2020

    - MarketWatch Automation

  7. Edwards Lifesciences Corp. stock rises Wednesday, outperforms market

    6:10 p.m. Dec. 2, 2020

    - MarketWatch Automation

  8. Edwards Lifesciences Corp. stock falls Tuesday, underperforms market

    6:10 p.m. Dec. 1, 2020

    - MarketWatch Automation

  9. Edwards Lifesciences Corp. stock falls Monday, underperforms market

    6:10 p.m. Nov. 30, 2020

    - MarketWatch Automation

  10. Edwards Lifesciences Corp. stock outperforms market on strong trading day

    6:24 p.m. Nov. 27, 2020

    - MarketWatch Automation

  11. Edwards Lifesciences Corp. stock rises Tuesday, still underperforms market

    6:09 p.m. Nov. 24, 2020

    - MarketWatch Automation

  12. Edwards Lifesciences Corp. stock rises Monday, still underperforms market

    6:09 p.m. Nov. 23, 2020

    - MarketWatch Automation

  13. Edwards Lifesciences Corp. stock falls Friday, underperforms market

    6:09 p.m. Nov. 20, 2020

    - MarketWatch Automation

  14. Edwards Lifesciences Corp. stock outperforms market on strong trading day

    6:09 p.m. Nov. 18, 2020

    - MarketWatch Automation

  15. Edwards Lifesciences Corp. stock outperforms market on strong trading day

    6:09 p.m. Nov. 17, 2020

    - MarketWatch Automation

  16. Edwards Lifesciences Corp. stock rises Monday, still underperforms market

    6:09 p.m. Nov. 16, 2020

    - MarketWatch Automation

  17. Loading more headlines...
/news/nonmarketwatch/company/us/ew

Other News on EW

  1. Wedgewood Partners Q4 2020 Client Letter

    7:05 p.m. Jan. 13, 2021

    - Seeking Alpha

  2. Bear of the Day: Penumbra (PEN)

    4:25 p.m. Jan. 8, 2021

    - Zacks.com

  3. A Quality Stock Index That Consistently Outperforms The Market

    8:07 a.m. Dec. 28, 2020

    - Seeking Alpha

  4. Expanded use of Edwards' Sapien 3 valve OK'd in Canada

    3:30 p.m. Dec. 18, 2020

    - Seeking Alpha

  5. Edwards Lifesciences (EW) Gets a Hold Rating from BTIG

    8:35 p.m. Dec. 10, 2020

    - SmarterAnalyst

  6. 7 ESG Investing Ideas That Could Add to Your Wallet and to Your Soul

    5:46 a.m. Nov. 30, 2020

    - InvestorPlace.com

  7. Oppenheimer Believes Edwards Lifesciences (EW) Won’t Stop Here

    12:05 p.m. Nov. 17, 2020

    - SmarterAnalyst

  8. 3 Strong, Margin-Expanding Stocks

    2:36 p.m. Nov. 5, 2020

    - GuruFocus.com

  9. Healthcare rallies as Presidential vote count continues

    12:12 p.m. Nov. 4, 2020

    - Seeking Alpha

  10. Loading more headlines...

At a Glance

Edwards Lifesciences Corp.

One Edwards Way

Irvine, California 92614

Phone

1 9492502500

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$4.35B

Net Income

$1.05B

2019 Sales Growth

16.8%

Employees

13,900

/news/pressrelease/company/us/ew

Press Releases on EW

  1. Loading more headlines...
Link to MarketWatch's Slice.